Lakeshore Biopharma Co Ltd's ability to collect accounts receivable sequentially worsen to 1.22, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Lakeshore Biopharma Co Ltd's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 299 days, from 235 days, in the 0 quarter.

If we take a look into Healthcare sector 544 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 0 to 3504.

What is Receivable Turnover Ratio?
What is Lakeshore Biopharma Co Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LSB Receivables Turnover Ratio	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2023) IV. Quarter
Y / Y Receivable Change	10.59 %	-2.5 %	-7.1 %	-7.1 %	-5.81 %
Y / Y Revenue Change	-19.18 %	-	-	-	-
Receivable Turnover Ratio (TTM)	1.22	1.55	1.54	1.51	1.49
LSB's Total Ranking	# 3504	# 0	# 0	# 0	# 0
Accounts Receivable average collection period days	299	235	237	241	246
Seq. Receivable Change	12.66 %	4.95 %	0 %	-6.47 %	-0.67 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 195
Healthcare Sector	# 545
Overall Market	# 3504

Receivable Turnover Ratio Statistics
High	Average	Low
1.29	1.29	1.29
(Mar 31 2024)

LSB Company Profile • Back to LSB Efficiency Comparisons • Compare LSB Receivables Turnover Ratio to its Competitors

Financial Statements
Lakeshore Biopharma Co Ltd's Accounts Receivable	$ 74 Millions	Visit LSB's Balance sheet
Lakeshore Biopharma Co Ltd's Sales TTM	$ 81 Millions	Visit LSB's Income Statement
Sources of LSB's Revenues		Visit LSB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LSB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LSB's Growth Rates	LSB's Roa	LSB's Inventory Turnover Ratio	LSB's Dividend Comparisons
LSB's Profitability Ratios	LSB's Roi	LSB's Asset Turnover Ratio	LSB's Dividend Growth
LSB's Valuation Ratios	LSB's Roe	LSB's Financial Strength Ratios	LSB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
C4 Therapeutics Inc	2.98	$ 20.036 Millions	$ 6.732 Millions
Evofem Biosciences Inc	2.97	$ 16.012 Millions	$ 5.391 Millions
Adc Therapeutics Sa	2.94	$ 68.619 Millions	$ 23.354 Millions
Axsome Therapeutics Inc	2.94	$ 251.023 Millions	$ 85.520 Millions
Assertio Holdings inc	2.92	$ 142.051 Millions	$ 48.587 Millions
Veru Inc	2.91	$ 12.291 Millions	$ 4.220 Millions
Alimera Sciences Inc	2.84	$ 89.029 Millions	$ 31.325 Millions
Apellis Pharmaceuticals Inc	2.78	$ 524.070 Millions	$ 188.613 Millions
Sage Therapeutics Inc	2.78	$ 91.063 Millions	$ 32.780 Millions
Sensus Healthcare Inc	2.73	$ 31.654 Millions	$ 11.576 Millions
Icad Inc	2.71	$ 15.961 Millions	$ 5.880 Millions
Cytokinetics Incorporated	2.68	$ 3.752 Millions	$ 1.400 Millions
Lexicon Pharmaceuticals Inc	2.61	$ 2.311 Millions	$ 0.885 Millions
Hyperfine Inc	2.58	$ 9.608 Millions	$ 3.729 Millions
Omega Therapeutics Inc	2.57	$ 4.938 Millions	$ 1.919 Millions
Intellia Therapeutics Inc	2.49	$ 52.604 Millions	$ 21.108 Millions
Regeneron Pharmaceuticals Inc	2.43	$ 13,100.100 Millions	$ 5,398.825 Millions
Ss Innovations International Inc	2.40	$ 9.143 Millions	$ 3.810 Millions
Verrica Pharmaceuticals Inc	2.35	$ 8.913 Millions	$ 3.799 Millions
Ocular Therapeutix Inc	2.31	$ 59.843 Millions	$ 25.906 Millions
Merus N v	2.27	$ 38.337 Millions	$ 16.856 Millions
Zevra Therapeutics Inc	2.26	$ 28.007 Millions	$ 12.410 Millions
Electromed Inc	2.24	$ 53.496 Millions	$ 23.905 Millions
60 Degrees Pharmaceuticals Inc	2.19	$ 0.342 Millions	$ 0.156 Millions
Allurion Technologies Inc	2.15	$ 47.037 Millions	$ 21.889 Millions
Silo Pharma Inc	2.09	$ 0.072 Millions	$ 0.034 Millions
Serina Therapeutics Inc	2.03	$ 0.099 Millions	$ 0.049 Millions
Amarin Corp Plcuk	2.02	$ 315.503 Millions	$ 156.496 Millions
Heron Therapeutics Inc	1.98	$ 131.550 Millions	$ 66.487 Millions
Petros Pharmaceuticals inc	1.93	$ 4.693 Millions	$ 2.434 Millions

Date modified: 2026-10-07T00:41:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.